1. Andreani A, Leonia A, Locatelli A, Morigi R, Rambaldi M, Simon WA, Senn-Bilfinger J (2000) Synthesis and antisecretory activity of 6-substitute cyanomethylimidazo[2,1-b]thiazoles and 2,6-dimethyl-5-hydroxylmethyl imidazo[2,1-b][1,3,4]thiadiazole. Arzneimittelforschung 50:550–553
2. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Int Med 163:1009–1021
3. Duncan K (1997) In antituberculosis drug resistance in the World the WHO/IUALTD. Global project on antituberculosis drug resistance surveillance. World Health Organization, Chem India, p 861
4. Foroumadi A, Emami S, Pournourmohammadi S, Kharazmi A, Shafiee A (2005) Synthesis and in vitro leishmanicidal activity of 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-5-substituted-1,3,4-thiadiazole derivatives. Eur J Med Chem 40:1346–1350
5. Franzblau SG, Witzig RS, McLaughlin JC, Torres P, Madico G, Hernandez A, Degnan MT, Cook MB, Quenzer VK, Ferguson RM, Gilman RH (1998) Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate alamar blue assay. J Clin Microbiol 36:362–366